Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant

Infection and Immunity

Volumn 67, Issue 1, 1999, Pages 342-349

  Yang, Chunfu ^a   Collins, William E ^a   Sullivan, Joann S ^a   Kaslow, David C ^b   Xiao, Lihua ^a   Lal, Altaf A ^a,c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; IMMUNIZATION; MALARIA; MEROZOITE; MONKEY; MONONUCLEAR CELL; NONHUMAN; PARASITEMIA; PLASMODIUM VIVAX; PRIORITY JOURNAL;

EID: 0032943177     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.1.342-349.1999     Document Type: Article

References (47)

1. al-Yaman, F., B. Genton, K. J. Kramer, S. P. Chang, G. S. Hui, M. Baisor, and M. P. Alpers. 1996. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinea children from malaria morbidity. Am. J. Trop. Med. Hyg. 54:443-448.
2. Arnot, D. E., J. W. Barnwell, J. P. Tam, V. Nussenzweig, R. S., Nussenzweig, and V. Enea. 1985. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. Science 230: 815-818.
3. Blackman, M. J., H. G. Heidrich, S. Donachie, J. S. McBride, and A. A. Holder. 1990. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:379-382.
4. Blackman, M. J., I. T. Ling, S. C. Nicholls, and A. A. Holder. 1991. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 49:29-34.
5. Burghaus, P. A., B. T. Wellde, T. Hall, R. L. Richards, A. F. Egan, E. M. Riley, W. P. Ballou, and A. A. Holder. 1996. Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection. Infect. Immun. 64:3614-3619.
6. Burns, J. M., Jr., L. A. Parke, T. M. Daly, L. A. Cavacini, W. P. Weidanz, and C. A. Long. 1989. A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii. J. Immunol. 142:2835-2840.
7. Chang, S. P., S. E. Case, W. L. Gosnell, A. Hashimoto, K. Kramer, L. Q. Tam, C. Q. Hashiro, C. M. Nikaido, and G. S. N. Hui. 1996. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:253-261.
8. Chappel, J. A., and A. A. Holder. 1993. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognize the first growth factor-like domain of merozoite surface protein-1. Mol. Biochem. Parasitol. 60:303-312.
9. Collins, W. E., and G. M. Jeffery. 1996. Primaquine resistance in Plasmodium max. Am. J. Trop. Med. Hyg. 55:243-249.
10. Cooper, J. A., L. T. Cooper, and A. J. Saul. 1992. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1. Mol. Biochem. Parasitol. 51:310-312.
11. Daly, T. M., and C. A. Lang. 1993. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect. Immun. 61: 2462-2467.
12. Daly, T. M., and C. A. Long. 1996. Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection. Infect. Immun. 64:2602-2608.
13. del Portillo, H. A., S. Longacre, E. Khouri, and P. H. David. 1991. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species Proc. Natl. Acad. Sci. USA 88:4030-4034.
14. de Oliveira, G. A., P. Clavijo, R. S. Nussenzweig, and E. H. Nardin. 1994. Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application. Vaccine 12:1012-1017.
15. Fang, X. D., D. C. Kaslow, J. H. Adams, and L. H. Miller, 1991. Cloning of the Plasmodium vivax duffy receptor. Mol. Biochem. Parasitol. 44:125-132.
16. Gibson, H. L., J. E. Tucker, D. C. Kaslow, A. U. Krettli, W. E. Collins, M. C. Kiefer, I. C. Bathurst, and P. J. Barr. 1992. Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax. Mol. Biochem. Parasitol. 50:325-334.
17. Høgh, B., N. T. Marbiah, P. A. Burghaus, and P. K. Andersen. 1995. Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic. Infect. Immun. 63:4034-4038.
18. Holder, A. A. 1988. The precursor to major merozoite surface antigens: structure and role in immunity. Prog. Allergy 41:72-97.
19. Hui, G. S. N., S. P. Chang, H. Gibson, A. Hashimoto, C. Hashiro, P. J. Barr, and S. Kotani. 1991. Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195. J. Immunol. 147:3935-3941.
20. Hui, G. S. N., C. Hashiro, C. Nikaido, S. E. Case, A. Hashimoto, H. Gibson, P. J. Barr, and S. P. Chang. 1993. Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus. Infect. Immun. 61:3403-3411.
21. Hunter, R. L., M. R. Kidd, M. R. Olsen, P. S. Patterson, and A. A. Lal. 1995. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. J. Immunol. 154:1762-1769.
22. Hunter, R. L., and A. A. Lal. 1994. Copolymer adjuvants in malaria vaccine development. Am. J. Trop. Med. Hyg. 50(Suppl.):52-58.
23. 5. I. Effects of carrier, copolymer adjuvants, and lipopolysaccharide on isotype selection. J. Immunol. 146:3583-3590.
24. 19, secreted from Saccharomyces cerevisiae. Immunol. Lett. 51:187-189.
25. Kenney, J. S., B. W. Hughes, M. P. Masada, and A. C. Allison. 1989. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J. Immunol. Methods. 121:157-166.
26. Kumar, S., A. Yadava, D. B. Keister, J. H. Tian, M. Ohl, Perdue-Greenfield, L. H. Miller, and D. C. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:325-332.
27. Levitus, G., and H. A. Del Portillo. 1994. Advances toward the development of an asexual blood stage MSP-1 vaccine of Plasmodium vivax. Mem. Inst. Oswaldo Cruz 89:81-84.
28. Ling, I. T., S. A. Ogun, P. Momin, R. L. Richards, N. Garcon, J. Cohen, W. R. Ballou, and A. A. Holder. 1997. Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use. Vaccine 15:1562-1567.
29. Long, C. A., T. M. Daly, P. Kima, and I. Srivastava. 1994. Immunity to erythrocytic stages of malarial parasites. Am. J. Trop. Med. Hyg. 50(Suppl.): 27-32.
30. Majarian, W. R. T. M. Daly, W. P. Weidanz, and C. A. Long. 1984. Passive immunization against murine malaria with an IgG3 monoclonal antibody. J. Immunol 132:3131-3137.
31. Panina-Bordignon, P., A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia. 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237-2242.
32. Perea, L., K. L. R., S. M. Handunnetti, I. Holm, and S. Longacre, and K. Mendis. 1998. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect. Immun. 66:1500-1506.
33. Pirson, P. J., and M. E. Perkins. 1985. Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. J. Immunol. 134:1946-1951.
34. Renia, L., I. T. Ling, M. Marussig, F. Miltgen, A. A. Holder, and D. Mazier. 1997. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge. Infect. Immun. 65:4419-4423.
35. 19) recognized by human antibodies. Parasite Immunol. 17:269-275.
36. Shi, Y. P., U. Sayed, S. H. Qari, J. M., Roberts, V. Udhayakumar, A. J. Oloo, W. A. Hawley, D. C. Kaslow, B. L. Nahlen, and A. A. Lal. 1996. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect. Immun. 64:2716-2723.
37. Snewin, V. A., E. Khouri, J. Wattavidanage, L. Perera, S. Premawansa, K. N. Mendis, and P. H. David. 1995. A new polymorphic marker for PCR typing of Plasmodium vivax parasites. Mol. Biochem. Parasitol. 71:135-138.
38. Sulzer, A. J., M. Wilson, and E. C. Hall. 1969. Indirect fluorescent antibody tests for parasitic disease. V. An evaluation of a thick-smear antigen in the IFA test for malarial antibodies. Am. J. Trop. Med. Hyg. 18:199-205.
39. Takayama, K., M. Olsen, P. Datta, and R. L. Hunter. 1991. Adjuvant activity of non-ionic block copolymers V. modulation of antibody isotype by lipopolysaccharides, lipid and precursors. Vaccine 9:257-265.
40. H2 cells in a rodent malaria infection. Science 260:1931-1934.
41. ten Hagen, T. L. M., A. J. Sulzer, M. R. Kidd, A. A. Lal, and R. L. Hunter. 1993. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. J. Immunol. 151:7077-7085.
42. Tian, J. H., S. Kumar, D. C. Kaslow, and L. H. Miller. 1997. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii. Infect. Immun. 65:3032-3036.
43. Triozzi, P. L., V. C. Stevens, W. Aldrich, J. Powell, C. W. Todd, and M. Newman. 1997. Effect of a β-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer. Clin. Cancer Res. 3:2355-2362.
44. Valmori, D., A. Pessi, E. Bianchi, and G. Corradin. 1992. Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immunol. 149:717-721.
45. van de Wijgert, J. H. H. M., A. F. M. Verheul, H. Snippe, I. J. Check, and R. L. Hunter. 1991. Immunogenicity of Streptococcus pneumaniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution. Infect. Immun. 59:2750-2757.
46. Yang, C., W. E. Collins, L. Xiao, P. S. Patterson, R. C. Reed, R. L. Hunter, D. C. Kaslow and A. A. Lal. 1996. Influence of adjuvants on murine immune responses against the C-terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein-1 (MSP-1). Parasite Immunol. 18:547-558.
47. Yang, C., W. E. Collins, L. Xiao, A. M Saekhou, R. C. Reed, C. O. Nelson, R. L. Hunter, D. L. Jue, S. Fang, R. M. Wohlhueter, V. Udhayakumar, and A. A. Lal. 1997. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus tosin. Vaccine. 15:377-386.